Project Number 1R41AG063616-01A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Reversal of Tau Pathology with MSUT2 siRNA Conjugates Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator SUCKOW, ARTHUR THOMAS Principal Investigator First Name ARTHUR Principal Investigator Last Name SUCKOW Awardee Organization DTX PHARMA, LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $213,027 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
